Only in Titles

           Search results for: Epithelial Membrane Antigen; Clone E29    

paperclip

#19788053   2009/09/30 Save this To Up

Podoplanin is a potential marker for the diagnosis of ependymoma: a comparative study with epithelial membrane antigen (EMA).

Podoplanin is a mucin-type transmembrane sialoglycoprotein that is characteristically expressed in lymphatic endothelia. It is also expressed in the ependyma of the central nervous system as well as in ependymomas. Particularly, membrane-bound structures along the luminal surface, ring-like structures, and dot-like structures in the cytoplasm, all of which were originally reported for epithelial membrane antigen (EMA) immunohistochemistry in ependymoma, were also reported for podoplanin immunohistochemistry in ependymoma. This study was undertaken to evaluate podoplanin as compared with EMA as a marker of ependymoma. A total of 16 ependymomas (WHO Grade (G) II, 9 cases; GIII, 4; myxopapillary, 2; GIII clear cell, (1) were immunohistochemically studied using antibodies against podoplanin (clones D2-40 and NZ-1) as well as an antibody against EMA (clone E29). In all cases, D2-40 and NZ-1 excellently labeled linear signals along the luminal surface of ependymal canals/rosettes, dot-like structures, and/or ringlike structures, as did E29. These structures were generally more abundant in GII ependymomas than in GIII ependymomas. A semiquantitative analysis between the immunopositive structures of D2-40 or NZ-1 and E29 was conducted with a focus on the dot-like structures and the ring-like structures in the cases of GII and GIII ependymoma. The result showed that there was no statistical difference between D2-40 or NZ-1 and E29. Our study suggests that podoplanin is a potential marker for the diagnosis of ependymoma that corresponds to EMA. Anti-podoplanin antibodies and anti-EMA antibodies could cooperate with each other for the diagnostic immunohistochemistry of ependymoma.

1404 related Products with: Podoplanin is a potential marker for the diagnosis of ependymoma: a comparative study with epithelial membrane antigen (EMA).

Mouse Anti-Epithelial Mem Epithelial Membrane Anti Epithelial Membrane Anti Epithelial Membrane Anti MOUSE ANTI BORRELIA BURGD Mouse Anti-Ca19.9 Sialyl Hamster AntiPodoplanin Ta MOUSE ANTI HUMAN EPITHELI MOUSE ANTI BOVINE ROTAVIR Rabbit Polyclonal to Myco Cell Meter™ JC 10 Mitoc Cell Meter™ JC 10 Mitoc

Related Pathways

paperclip

#15690334   2005/02/10 Save this To Up

The value of epithelial membrane antigen expression in separating benign mesothelial proliferation from malignant mesothelioma: a comparative study.

Differentiating reactive mesothelial (RM) proliferation from malignant mesothelioma (MM) can be cytologically challenging. There have been discordant studies reporting the value of epithelial membrane antigen (EMA) in differentiating RM from MM. In this study, we investigated the expression of two different clones of EMA in RM and MM. Twenty cases of pleural effusion smears of RM and 20 cases of MM with their corresponding cell blocks were retrieved from the hospital computer system. Diagnosis of MM was confirmed by surgical decortication or pneumonectomy with immunostaining studies and/or electron microscopy. Cases of RM were confirmed by clinical history and histology. Cell blocks were formalin-fixed, paraffin-embedded, and immunostained for EMA clone Mc5 and EMA clone E29. The positive rates for clone Mc5 were 14/20 (70%) for MM and 12/20 (60%) for RM and EMA clone E29 were 15/20 (75%) for MM and 0/20 (0%) for RM. The sensitivity and specificity for EMA clone Mc5 were 70 and 40%, respectively. For EMA clone E29, the sensitivity and specificity were 75 and 100%, respectively. In conclusion, both RM and MM immunostained for EMA clone Mc5, indicating that it is not a reliable immunocytochemical marker for differentiating RM from MM. EMA clone E29 was negative in all cases of RM and positive in 75% of MM and therefore is a reliable immunocytochemical marker for differentiating RM from MM.

2224 related Products with: The value of epithelial membrane antigen expression in separating benign mesothelial proliferation from malignant mesothelioma: a comparative study.

Epithelial Membrane Anti Epithelial Membrane Anti Epithelial Membrane Anti MOUSE ANTI HUMAN EPITHELI Mouse Anti-Epithelial Mem Malignant melanoma, metas Tissue array of ovarian g Mesothelioma test tissue HIV 1 intergase antigen. DNA (cytosine 5) methyltr anti H inh human blood an H. Pylori antigen test ca

Related Pathways

paperclip

#15309883   2004/08/16 Save this To Up

Prognostic significance of mucin expression in gastric carcinoma.

In patients with gastric carcinomas, the role of the alteration of mucin expression in overall survival has been a matter of some speculation, but few studies have been reported. The aim of our study was to determine the relationship between MUC1, MUC2, and MUC5AC expression and patient survival, with a secondary aim designed to investigate the alteration of MUC expression within various clinicopathologic parameters. Forty-four specimens from gastric carcinoma patients were immunohistochemically evaluated using the monoclonal antibodies for MUC1 (EMA, clone E29), MUC2 (CCP58), and MUC5AC (human gastric mucin, clone 45M1). MUC1 expression increased in gastric carcinoma. MUC1 positivity was determined to be statistically significant, with poor clinicopathological parameters and decreased long-term survival. MUC5AC expression decreased in gastric carcinoma. In addition, patients with MUC5AC-positive tumors also had poor clinicopathological parameters and showed shorter survival than those with MUC5AC-negative tumors. MUC2 expression was not significantly associated with patient survival. We confirmed that the expression of mucins is associated with characteristics of differentiation in gastric carcinoma. Poor patient outcomes were seen in gastric carcinomas with MUC1 mucin expression and MUC5AC positivity.

1097 related Products with: Prognostic significance of mucin expression in gastric carcinoma.

GI cancer (esophageal, ga Tissue array of gastritis Gastric carcinoma, gastri DNA (cytosine 5) methyltr Multi organ carcinoma tis Multi organ carcinoma tis Pancreatic carcinoma and Tissue array of gastric d Liver carcinoma and norma Liver carcinoma and norma Liver carcinoma and norma Lung carcinoma and normal

Related Pathways

paperclip

#14555387   2003/10/13 Save this To Up

Epithelial membrane antigen (EMA) or MUC1 expression in monocytes and monoblasts.

Epithelial membrane antigen (EMA) or MUC1 belongs to a heterogeneous group of heavily glycosylated proteins and is expressed in most normal and epithelial neoplastic cells. EMA is also expressed in plasma cells, anaplastic large cell lymphoma (Ki-1 antigen), malignant histiocytosis and erythroleukaemia. In 1996, Cheong et al. (Hematology 1996; 1: 223) demonstrated the positive expression of EMA in monoblasts. Since there were very few useful markers for differentiating subtypes of acute myeloid leukaemia with a monocytic component from the those without, a study was conducted to evaluate the prevalence of EMA expression and its relationship with known markers for monocytic-macrophage lineage (CD11c, CD14 and intracellular CD68) in monocytes and monoblasts.

2316 related Products with: Epithelial membrane antigen (EMA) or MUC1 expression in monocytes and monoblasts.

Mouse Anti-Epithelial Mem Epithelial Membrane Anti Epithelial Membrane Anti Epithelial Membrane Anti MOUSE ANTI HUMAN EPITHELI HEV (Birma) ORF2 recombin HEV (Birma) ORF2 recombin HEV (Birma) ORF2 recombin HIV 1 intergase antigen. VZV ORF9 recombinant anti VZV ORF26 recombinant ant DNA (cytosine 5) methyltr

Related Pathways

paperclip

#3553440   1987/06/12 Save this To Up

Cross reactivity of anti-epithelial membrane antigen monoclonal for reactive and neoplastic glial cells.

An anti-epithelial membrane antigen monoclonal (Clone E29) was used as part of a panel of antisera in the investigation of primary CNS and metastatic tumours. In contrast to others, definite and often strongly positive cross-reactivity has been demonstrated on glial cells. The material consisted of fourteen astrocytomas, two ependymomas, six cerebral metastases and two cases of gliosis.

2013 related Products with: Cross reactivity of anti-epithelial membrane antigen monoclonal for reactive and neoplastic glial cells.

MOUSE ANTI HUMAN EPITHELI Anti C Reactive Protein A MOUSE ANTI BORRELIA BURGD Mouse Anti-Epithelial Mem Epithelial Membrane Anti Epithelial Membrane Anti Epithelial Membrane Anti MOUSE ANTI BOVINE ROTAVIR anti HSV (II) gB IgG1 (mo anti HCMV IE pp65 IgG1 (m anti HCMV gB IgG1 (monocl anti HBsAg surface antige

Related Pathways